Worldwide, 350,000 women die from cervical cancer, the most common HPV cancer. “I think we can all agree that one dose and two doses of … these fantastic vaccines work really well,” said ...

SEATTLE — Since its approval by the U.S. Food and Drug Administration in 2006, the HPV vaccine has made considerable strides in preventing cervical and oropharyngeal, or throat cancers.